Effects of lncRNA ANRIL‑knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells

Hu,Xueqian; Lou,Ting; Yuan,Chunying; Wang,Yongsheng; Tu,Xiaolong; Wang,Yi; Zhang,Tingsu

doi:10.3892/ol.2021.12882

Effects of lncRNA ANRIL‑knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells

Authors:
- Xueqian Hu
- Ting Lou
- Chunying Yuan
- Yongsheng Wang
- Xiaolong Tu
- Yi Wang
- Tingsu Zhang
View Affiliations

Affiliations: Department of Oncology, Ningbo Municipal Hospital of Traditional Chinese Medicine, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, Zhejiang 315000, P.R. China
Published online on: June 28, 2021 https://doi.org/10.3892/ol.2021.12882
Article Number: 621
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer is one of the most common types of malignant tumor of the gastrointestinal tract worldwide. Cisplatin (DDP) is a commonly used chemotherapeutic drug in the clinic; however, the resistance of gastric cancer cells to DDP limits its efficacy. In the present study, drug‑resistant gastric cancer cell lines were constructed using the stepwise continuous selection method, and the relative expression levels of long non‑coding RNA (lncRNA) CDKN2B antisense RNA 1 (ANRIL) and microRNA (miR)‑181a‑5p were detected using reverse transcription‑quantitative PCR. The knockdown of lncRNA ANRIL and miR‑181a‑5p expression was performed by transfection with shRNA‑ANRIL and an miR‑181a‑5p inhibitor, respectively. Cellular proliferation and sensitivity to DDP were assessed using Cell Counting Kit‑8 analysis. Cell apoptosis and cell cycle distribution were assessed using flow cytometry and western blotting. The binding relationships between ANRIL, miR‑181a‑5p and cyclin G1 (CCNG1) were verified using a dual luciferase reporter assay. The results revealed that the expression levels of miR‑181a‑5p were downregulated in all drug‑resistant cell lines. ANRIL‑knockdown inhibited cellular proliferation, and promoted apoptosis and cell cycle arrest; however, following the knockdown of miR‑181a‑5p, the inhibition of cell cycle arrest was alleviated. Notably, miR‑181a‑5p, ANRIL and CCNG1 were found to have targeting relationships. In conclusion, the findings of the present study suggested that knocking down the expression of ANRIL inhibited cellular proliferation, and promoted apoptosis and cell cycle arrest. Furthermore, its downstream target, miR‑181a‑5p, inhibited the proliferation of drug‑resistant cells and enhanced their sensitivity to DDP.

View Figures

View References

1	Taft RJ, Pheasant M and Mattick JS: The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays. 29:288–299. 2007. View Article : Google Scholar : PubMed/NCBI
2	Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et al: The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
3	Fidler IJ, Yano S, Zhang RD, Fujimaki T and Bucana CD: The seed and soil hypothesis: Vascularisation and brain metastases. Lancet Oncol. 3:53–57. 2002. View Article : Google Scholar : PubMed/NCBI
4	Ellis LM and Hicklin DJ: VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI
5	Wang C, Wen Z, Xie J, Zhao Y, Zhao L, Zhang S, Liu Y, Xue Y and Shi M: MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer. Biochem Biophys Res Commun. 485:665–671. 2017. View Article : Google Scholar : PubMed/NCBI
6	Hombach S and Kretz M: Non-coding RNAs: Classification, biology and functioning. Adv Exp Med Biol. 937:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
7	Bhan A and Mandal SS: Long noncoding RNAs: Emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
8	Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
9	Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW and Jenkins RB: Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet. 92:136–141. 2000. View Article : Google Scholar : PubMed/NCBI
10	Shen XH, Qi P and Du X: Long non-coding RNAs in cancer invasion and metastasis. Mod Pathol. 28:4–13. 2015. View Article : Google Scholar : PubMed/NCBI
11	Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
12	Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin Y, Wu S, Mou X and Zhu Y: ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma. Cell Immunol. 289:91–96. 2014. View Article : Google Scholar : PubMed/NCBI
13	Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, et al: Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
14	Rupaimoole R and Slack FJ: MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
15	Lin F, Li Y, Yan S, Liu S, Qian W, Shen D, Lin Q and Mao W: MicroRNA-181a inhibits tumor proliferation, invasiveness, and metastasis and is downregulated in gastric cancer. Oncol Res. 22:75–84. 2015. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Li JH, Liu S, Zhou H, Qu LH and Yang JH: starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
18	Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
19	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
20	Enright AJ, John B, Gaul U, Tuschl T, Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol. 5:R12003. View Article : Google Scholar : PubMed/NCBI
21	Oda I, Shimazu T, Ono H, Tanabe S, Iishi H, Kondo H and Ninomiya M: Design of Japanese multicenter prospective cohort study of endoscopic resection for early gastric cancer using web registry (J-WEB/EGC). Gastric Cancer. 15:451–454. 2012. View Article : Google Scholar : PubMed/NCBI
22	Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL and Weir HK: Stomach cancer survival in the United States by race and stage (2001–2009): Findings from the CONCORD-2 study. Cancer. 123 (Suppl 24):S4994–S5013. 2017. View Article : Google Scholar
23	Song Z, Wu Y, Yang J, Yang D and Fang X: Progress in the treatment of advanced gastric cancer. Tumour Biol. 39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
24	Li Y, Lv S, Ning H, Li K, Zhou X, Xv H and Wen H: Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Biomed Pharmacother. 108:1775–1782. 2018. View Article : Google Scholar : PubMed/NCBI
25	Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y and Yang M: Noncoding RNAs in gastric cancer: Implications for drug resistance. Mol Cancer. 19:622020. View Article : Google Scholar : PubMed/NCBI
26	Xu Y, Zhang Q, Miao C, Dongol S, Li Y, Jin C, Dong R, Li Y, Yang X and Kong B: CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer Med. 8:351–362. 2019. View Article : Google Scholar : PubMed/NCBI
27	Han H, Zhang Z, Yang X, Yang W, Xue C and Cao X: miR-23b suppresses lung carcinoma cell proliferation through CCNG1. Oncol Lett. 16:4317–4324. 2018.PubMed/NCBI
28	Ye XX, Liu CB, Chen JY, Tao BH and Zhi-Yi C: The expression of cyclin G in nasopharyngeal carcinoma and its significance. Clin Exp Med. 12:21–24. 2012. View Article : Google Scholar : PubMed/NCBI
29	Zhang D, Sun G, Zhang H, Tian J and Li Y: Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 85:511–516. 2017. View Article : Google Scholar : PubMed/NCBI
30	Chen G, Shen ZL, Wang L, Lv CY, Huang XE and Zhou RP: hsa-miR-181a-5p expression and effects on cell proliferation in gastric cancer. Asian Pac J Cancer Prev. 14:3871–3875. 2013. View Article : Google Scholar : PubMed/NCBI
31	Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H, Fang G and Xue X: MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis. Open Biol. 9:1900952019. View Article : Google Scholar : PubMed/NCBI
32	Ghaedi H, Mozaffari MAN, Salehi Z, Ghasemi H, Zadian SS, Alipoor S, Hadianpour S and Alipoor B: Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Gene. 687:135–142. 2019. View Article : Google Scholar : PubMed/NCBI
33	Capizzi M, Strappazzon F, Cianfanelli V, Papaleo E and Cecconi F: MIR7-3HG, a MYC-dependent modulator of cell proliferation, inhibits autophagy by a regulatory loop involving AMBRA1. Autophagy. 13:554–566. 2017. View Article : Google Scholar : PubMed/NCBI
34	Lan WG, Xu DH, Xu C, Ding CL, Ning FL, Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI